Digestive System TRIZ Cases

A pharmaceutical composition containing a Gymnaster koraiensis extract inhibits fat accumulation in liver tissue.

A solid oral lozenge combines plant oils with gelatin to deliver lubrication.

A stable crystal form of a caspase inhibitor compound exhibits low hygroscopicity and high structural integrity for pharmaceutical use.

Eluxadoline synthesis overcomes low yield and waste generation by optimizing solvent selection and temperature to isolate pure product directly.

Sicyos angulatus extract suppresses reactive oxygen species and inhibits inflammatory cytokines in hepatocytes.

Guselkumab achieves clinical remission through a specific intravenous induction and subcutaneous maintenance dosing regimen.

Antibiotics eliminate ClpB-expressing gut bacteria, resolving the molecular mimicry of alpha-MSH that triggers auto-antibodies causing eating disorders.

HK4 reduces caspase 3/7 activity and modulates NF-kB signaling to treat non-alcoholic fatty liver disease.

Intravenous sotalol hydrochloride loading and maintenance protocols enable targeted antiarrhythmic therapy in cardiothoracic surgery patients.

Engineered antibodies target sialyl Lewis A and C antigens to reduce inflammation in colitis models while avoiding cross-reactivity with sialyl Lewis X.

Oral Chlamydomonas algal preparation stabilizes weight and reduces diarrhea incidence in mammalian gastrointestinal models.

Specific GPIb alpha binding impairs thrombin interaction, reducing NAFLD progression and HCC risk without broad side effects.

Plant sterol-derived steroid 6,7-beta-epoxides resolve supply constraints and contamination risks in obeticholic acid synthesis.

Renalase-binding antibodies enable precise detection of renalase levels through high-affinity molecular interactions.

Anti-PD-L1 antibody combined with VEGF antagonist overcomes tumor immune evasion by blocking PD-1 signaling while inhibiting angiogenesis.

Serum anti-nervous system ganglioside antibodies detect proventricular dilatation disease without invasive tissue biopsy risks.

A starch-based coating composition controls swelling via a water-insoluble polymer to deliver active ingredients directly to the colon.

A dialysis apparatus selectively removes albumin and endotoxin from blood using a 50-100 kDa membrane.

Specific antibodies target aberrant EGFR signaling to treat cancers lacking effective antagonists.

Post-exposure small peptide administration reduces acute radiation injury mortality without pre-exposure toxicity.

Branched-chain amino acids mitigate hand-foot syndrome and bleeding from sorafenib, enabling prolonged anticancer treatment.

Polygenic risk scores stratify Crohn's disease patients by genetic variants to target TL1A inhibitors, resolving non-response variability in standard therapies.

Hydrophobic plant fat matrices encapsulate macrogol, preserving osmotic pressure in the colon and reducing daily doses to minimize bloating.

Alisporivir binds cyclophilin proteins to inhibit HBV and HDV replication, reducing HBsAg production and liver damage without immunosuppressive side effects.

Oral secretory IgA resolves IVIg treatment complications by inducing mucosal tolerance and limiting pro-inflammatory pathways.

A self-assembling peptide hydrogel forms at the resection site to promote healing.

Recombinant VHH fragments provide passive immunity against rotavirus diarrhea without requiring complex antibody production or raising safety concerns.

Ethanol extraction produces clear granules that resolve turbidity issues and ensure accurate pediatric dosing.

LANCL2 ligands activate signaling pathways to modulate immune and metabolic functions, addressing underlying immunometabolic imbalances in disease treatment.

Alkoxy pyrazole compounds activate soluble guanylate cyclase to reduce portal pressure and inhibit hepatic fibrosis.

A bispecific antibody binds the epidermal growth factor receptor family and the WNT signaling pathway to inhibit cancer stem cell proliferation.

Monitoring free GPC3 concentration in biological samples determines therapy efficacy for hepatocellular cancer patients.

Methanobactins reduce liver copper levels and restore mitochondrial function without severe toxicity.

Modulating BMP and Activin signaling generates human pluripotent stem cell-derived venous endothelial cells with high engraftment potential.

Nutritional composition soothes liver using segmented rice and herbal modules, resolving formulation complexity and taste trade-offs.

A probiotic composition reduces hepatocellular carcinoma growth through immunomodulatory mechanisms.